Manager × security

PERCEPTIVE ADVISORS LLC SYRE holdings history

Who else holds this security? →

SPYRE THERAPEUTICS INC · CUSIP 00773J202 · CIK 1224962

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, PERCEPTIVE ADVISORS LLC reported 4.32M SYRE (shares), valued at $383.48M, or 5.95% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
5.95%
Shares
4.32M
4,319,496
Reported value
$383.48M
USD

Shares increased 14.17%; reported value increased 100.96%, and weight changed +2.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20265.95%4,319,496SEC filing ↗Filed Aug 14, 2026
Q1 20263.77%3,783,225SEC filing ↗Filed May 29, 2026Amended
Q4 20251.84%3,069,225SEC filing ↗Filed Feb 17, 2026
Q3 20250.60%1,229,445SEC filing ↗Filed Nov 14, 2025
Q2 20250.86%1,529,445SEC filing ↗Filed Aug 14, 2025
Q1 20251.32%2,313,272SEC filing ↗Filed Aug 6, 2025Amended
Q4 20241.67%2,574,723SEC filing ↗Filed Feb 14, 2025
Q3 20241.81%2,872,547SEC filing ↗Filed Nov 14, 2024
Q2 20241.72%3,031,018SEC filing ↗Filed Aug 16, 2024Amended
Q1 20241.71%2,556,679SEC filing ↗Filed Aug 6, 2024Amended
Q4 20231.25%2,606,679SEC filing ↗Filed Feb 26, 2024Amended
Q3 20230.03%81,116SEC filing ↗Filed Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.03%81,116$993.67KThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 20231.25%2,606,679$56.10MShares increased 3113.52%; reported value increased 5545.30%, and weight changed +1.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 26, 2024
Q1 20241.71%2,556,679$96.97MShares decreased 1.92%; reported value increased 72.87%, and weight changed +0.46 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 6, 2024
Q2 20241.72%3,031,018$71.26MShares increased 18.55%; reported value decreased 26.52%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 16, 2024
Q3 20241.81%2,872,547$84.48MShares decreased 5.23%; reported value increased 18.56%, and weight changed +0.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20241.67%2,574,723$59.94MShares decreased 10.37%; reported value decreased 29.05%, and weight changed -0.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20251.32%2,313,272$37.32MShares decreased 10.15%; reported value decreased 37.73%, and weight changed -0.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 6, 2025
Q2 20250.86%1,529,445$22.90MShares decreased 33.88%; reported value decreased 38.66%, and weight changed -0.46 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20250.60%1,229,445$20.61MShares decreased 19.61%; reported value decreased 10.00%, and weight changed -0.26 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20251.84%3,069,225$100.55MShares increased 149.64%; reported value increased 387.97%, and weight changed +1.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20263.77%3,783,225$190.83MShares increased 23.26%; reported value increased 89.79%, and weight changed +1.93 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 29, 2026
Q2 20265.95%4,319,496$383.48MShares increased 14.17%; reported value increased 100.96%, and weight changed +2.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
PERCEPTIVE ADVISORS LLC · SPYRE THERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1224962","quarter":"2026Q2","cusip":"00773J202"}

get_institutional_manager_history
{"cik":"1224962","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.